List of Figures:
Figure 2-1: Vaccines Horizon (1960 to 2010)
Figure 2-2: Global - Vaccine Market by Player (%), 2008
Figure 2-3: Global - Vaccine Market by Region (%), 2008
Figure 2-4: Global - Forecast for Vaccine Market (Billion US$), 2009-2012
Figure 3-1: Global - Mortality and Morbidity of Diseases Preventable by Vaccine (‘000)
Figure 3-2: Global - Profit Margin of Vaccines, Generics and Branded Drugs (%), 2007
Figure 3-3: Global - Vaccine Market by Source of Funding (%), 2005 to 2010
Figure 3-4: Global - Prevnar Sales (Billion US$), 2007 & 2008
Figure 3-5: Global - Gardasil Sales (Billion US$), 2007 & 2008
Figure 3-6: Global - Dose Consumption and Revenue by Regional Income (%), 2005
Figure 4-1: Global - Vaccine Market by Segment (%), 2007 & 2008
Figure 4-2: Global - Forecast for Vaccine Market by Segment (%), 2009-2012
Figure 4-3: Global - Basic Pediatric Vaccine Market (Million US$), 2006-2008
Figure 4-4: Global - Forecast for Basic Pediatric Vaccine Market (Million US$), 2009-2012
Figure 4-5: Global - Enhanced Pediatric Vaccine Market (Million US$), 2006-2008
Figure 4-6: Global - Forecast for Enhanced Pediatric Vaccine Market (Million US$), 2009-2012
Figure 4-7: Global - Proprietary Pediatric Vaccine Market (Million US$), 2006-2008
Figure 4-8: Global - Forecast for Proprietary Pediatric Vaccine Market (Million US$), 2009-2012
Figure 4-9: Global - Share of Adult Vaccine Sales in Vaccine Market (2006 & 2007)
Figure 4-10: Global - Adult Vaccine Market (Billion US$), 2006-2008
Figure 4-11: Global - Forecast for Adult Vaccine Market (Billion US$), 2009-2012
Figure 4-12: Global - Cancer Vaccine Market (Million US$), 2007, 2008 & 2012
Figure 4-13: Global - Number of Cancer Vaccines in Various Phases of Clinical Developments by Type (Aug 2005)
Figure 4-14: Global - Forecast for Addiction Vaccine Market (Million US$), 2009-2012
Figure 4-15: Global - Influenza Vaccine Market (Billion US$), 2009-2012
Figure 5-1: Global - Pipeline for Pneumococcal Vaccines
Figure 5-2: Global - Pneumococcal Vaccine Market (Million US$), 2007 & 2012
Figure 5-3: Global - Number of Polio Incidences (2006-2008)
Figure 5-4: Global - Countries with Maximum Number of Polio Incidences (2008)
Figure 5-5: Global - Polio Vaccine Market (Million US$), 2004 & 2011
Figure 5-6: Global - Varicella Vaccine Market (Million US$), 2007 & 2008
Figure 5-7: Global - Forecast for Meningitis Vaccine Demand for Epidemic Response (Million Doses) 2009-2012
Figure 5-8: US & Europe - Meningitis Vaccines Market Potential (Million)
Figure 5-9: Global - Forecast for Meningitis Vaccine Market (Million US$), 2009 & 2010
Figure 5-10: Global - Rotavirus Vaccine Market (Million US$), 2007 & 2010
Figure 5-11: Global - Forecast for Rotavirus Vaccine Market by Region (%), 2010
Figure 5-12: Global - Number of Diphtheria Incidences by Region (2007)
Figure 5-13: Global - Number of Pertussis Incidences by Region (2007)
Figure 5-14: Global - Number of nTetanus Incidences by Region (2007)
Figure 5-15: Global - Number of tTetanus Incidences by Region (2007)
Figure 5-16: Global - DTP Combos Market by Player (%), 2004
Figure 5-17: Global - Number of Measles Incidences by Region (2007)
Figure 5-18: Global - Number of Mumps Incidences by Region (2007)
Figure 5-19: Global - Number of Rubella Incidences by Region (2007)
Figure 5-20: Global - Number of Tuberculosis Incidences by Region (‘000), 2007
Figure 6-1: Global - Hepatitis B Surface Antigen Prevalence (%), 2006
Figure 6-2: Global - Hepatitis B Vaccine Market (Billion US$), 2009-2012
Figure 6-3: Global - R&D Investment in AIDS Vaccine Development (Million US$), 2006-2008
Figure 6-4: Global - Sources for Funding in HIV Vaccine R&D (%), 2007
Figure 6-5: Global - HIV Funding Allocation by Category (%), 2007
Figure 7-1: Global - Vaccine Market by Region (%), 2008
Figure 7-2: Global - Forecast for Vaccine Market by Region (%), 2012
Figure 7-3: Global - Sales Split of Major Vaccine Players by Region (%), 2004
Figure 7-4: US - Vaccine Market (Billion US$), 2008-2012
Figure 7-5: US - Forecast for Pediatric Vaccine Market (Billion US$), 2009-2012
Figure 7-6: US - Hepatitis Vaccine Market (Billion US$), 2008-2012
Figure 7-7: US - Biodefense Vaccine Market (Million US$), 2008-2012
Figure 7-8: US - Influenza Vaccine Production and Consumption (Million Doses), 2004-2005 to 2007-2008
Figure 7-9: US - Influenza Vaccine Sales by Provider (%), 2007-2008
Figure 7-10: US - Influenza Vaccine Market (Million US$), 2008-2012
Figure 7-11: US - Travel Vaccine Market (Million US$), 2008-2012
Figure 7-12: US - Developmental Vaccine Market (Million US$), 2008-2012
Figure 7-13: Europe - Vaccine Market (Billion US$), 2007, 2008 & 2014
Figure 7-14: China - Vaccine Market (Million US$), 2006-2008
Figure 7-15: China - Forecast for Vaccine Market (Million US$), 2009-2012
Figure 7-16: China - Comparison of Annual Growth Rate of Vaccine Market with World (%)
Figure 7-17: China - Influenza Vaccine Market (Million US$) 2007 & 2008
Figure 7-18: China - Forecast for Influenza Vaccine Market (Million US$), 2009-2012
Figure 7-19: India - Share of Domestic Consumption and Exports in Vaccine Market (2007-08)
Figure 7-20: India - Share of Private Sector in Domestic Vaccine Market (2007-08)
Figure 7-21: India - Vaccine Market (Million US$), 2007-08 & 2008-09
Figure 7-22: India - Share of Major Players in Vaccine Market (2006-07)
Figure 7-23: India - Forecast for Vaccine Market (Million US$) 2009-10 to 2011-12
Figure 7-24: Japan - Vaccine Market (Million US$), 2007 & 2008
Figure 7-25: Japan - Influenza Vaccine Production (Million Doses), 2007-08 & 2008-09
Figure 7-26: Japan - Forecast for Vaccine Market (Million US$), 2009-2012
Figure 7-27: Brazil - Vaccine Market (Million BRL), 2007 & 2008
Figure 7-28: Brazil - Forecast for Vaccine Market (Million BRL), 2009-2012
Figure 7-29: Brazil - Share of Public and Private Sectors in Vaccine Market (2004)
Figure 8-1: Global - Share of Major Players in Vaccine Market (2007)
Figure 8-2: Global - Forecast for Share of Major Players in Vaccine Market (2012)
Figure 8-3: Global - Forecast for CAGR of Major Players in Vaccine Market (%), 2009 to 2012
List of Tables:
Table 2-1: Global - Top Selling Vaccines by Brand (Billion US$), 2008
Table 2-2: Global - Vaccine Sales of Top Companies (Million US$), 2008
Table 2-3: Recent Developments in Vaccine Market
Table 2-4: Global - Revenue from Major Therapy Areas (Million US$), 2007 & 2012
Table 3-1: Global - Number of Deaths due to Diphtheria Averted by Vaccines (‘000), 2001
Table 3-2: Health Statistics in Developed and Developing Countries (%)
Table 4-1: US - Estimated Number of New Cancer Cases and Deaths (2008)
Table 4-2: Global - Five Year Relative Survival Rates by Stage of Cancer Diagnosis (%)
Table 4-3: Global - List of Launched and Under-development Cancer Vaccines by Indication
Table 5-1: Global - Pneumococcal Vaccine Supply
Table 6-1: Global - Number of HIV/AIDS Patients (2007)
Table 7-1: US - Influenza Vaccine Production (Million Doses), 2007-2008 & 2008-2009
Table 7-2: China - Number of Reported Cases of Diseases Preventable by Vaccine (2006 & 2007)
Table 7-3: China - Vaccine Classification
Table 7-4: China - Pediatric Vaccine Doses Requirement (Million)
Table 7-5: Brazil - Public and Private Sector Vaccine Market (Million BRL), 2000
Table 8-1: Global - Forecast for Top Launched Vaccine Brand Sales (Billion US$), 2009 & 2012
Table 8-2: Global - Forecast for Top Vaccine Brand Sales Under-development (Million US$), 2012
Table 8-3: Global - Key Mergers & Acquisitions in Vaccine Market (2005 to 2008)
Table 8-4: Global - Major Vaccine Companies (Segmentation by Revenue)
